Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence.

Beau-Lejdstrom R, Douglas I, Evans SJ, Smeeth L.

BMJ Open. 2016 Jun 13;6(6):e010508. doi: 10.1136/bmjopen-2015-010508.

2.

National trends in off-label use of atypical antipsychotics in children and adolescents in the United States.

Sohn M, Moga DC, Blumenschein K, Talbert J.

Medicine (Baltimore). 2016 Jun;95(23):e3784. doi: 10.1097/MD.0000000000003784.

3.

Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study.

Hartz I, Skurtveit S, Steffenak AK, Karlstad Ø, Handal M.

BMC Psychiatry. 2016 Jan 29;16:12. doi: 10.1186/s12888-016-0716-x.

4.

Comparative efficacy and tolerability of first-generation and newer-generation antidepressant medications for depressive disorders in children and adolescents: study protocol for a systematic review and network meta-analysis.

Zhou X, Qin B, Whittington C, Cohen D, Liu Y, Del Giovane C, Michael KD, Zhang Y, Xie P.

BMJ Open. 2015 Sep 9;5(9):e007768. doi: 10.1136/bmjopen-2015-007768. Review.

5.

Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.

de Bie S, Ferrajolo C, Straus SM, Verhamme KM, Bonhoeffer J, Wong IC, Sturkenboom MC; GRiP network.

PLoS One. 2015 Jun 19;10(6):e0130399. doi: 10.1371/journal.pone.0130399. eCollection 2015.

6.

Use of psychotropics among looked after children: an audit in the Borough of Lambeth.

Pinto C, Barrett N.

London J Prim Care (Abingdon). 2010 Jul;3(1):52-7.

7.

Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.

Logan SL, Carpenter L, Leslie RS, Garrett-Mayer E, Hunt KJ, Charles J, Nicholas JS.

J Child Adolesc Psychopharmacol. 2015 May;25(4):323-36. doi: 10.1089/cap.2013.0119. Epub 2015 Apr 28.

8.

Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents.

Sohn M, Talbert J, Blumenschein K, Moga DC.

Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):583-91. doi: 10.1002/pds.3768. Epub 2015 Mar 23.

9.

Public health nurses' perception of their roles in relation to psychotropic drug use by adolescents: a phenomenographic study.

Steffenak AK, Nordström G, Hartz I, Wilde-Larsson B.

J Clin Nurs. 2015 Apr;24(7-8):970-9. doi: 10.1111/jocn.12716. Epub 2015 Jan 8.

10.

The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states.

Stein BD, Leckman-Westin E, Okeke E, Scharf DM, Sorbero M, Chen Q, Chor KH, Finnerty M, Wisdom JP.

J Child Adolesc Psychopharmacol. 2014 Sep;24(7):374-81. doi: 10.1089/cap.2014.0008. Epub 2014 Aug 21.

11.

Patterns of psychotropic medication prescriptions by psychiatrists for private clinic outpatients in kerman province, iran.

Sabahi A, Sepehri G, Mohsenbeigi M, Sepehri E.

Sultan Qaboos Univ Med J. 2014 Aug;14(3):e382-7. Epub 2014 Jul 24.

12.

A translational neuroscience perspective on the importance of reducing placement instability among foster children.

Fisher PA, Mannering AM, Van Scoyoc A, Graham AM.

Child Welfare. 2013;92(5):9-36. Review. No abstract available.

13.

Psychological and drug abuse symptoms associated with nonmedical use of opioid analgesics among adolescents.

Boyd CJ, Young A, McCabe SE.

Subst Abus. 2014;35(3):284-9. doi: 10.1080/08897077.2014.928660.

14.

Use of Psychotropic Medications among Youth in Treatment Foster Care.

Brenner SL, Southerland DG, Burns BJ, Wagner HR, Farmer EM.

J Child Fam Stud. 2014 May 1;23(4):666-674.

15.

Psychotropic medication characteristics for special education students with emotional and/or behavioral disorders.

Mattison RE, Rundberg-Rivera V, Michel C.

J Child Adolesc Psychopharmacol. 2014 Aug;24(6):347-53. doi: 10.1089/cap.2013.0073. Epub 2014 Feb 7.

17.

The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children.

Dunn AG, Mandl KD, Coiera E, Bourgeois FT.

PLoS One. 2013 Dec 23;8(12):e84951. doi: 10.1371/journal.pone.0084951. eCollection 2013.

18.

National trends in psychotropic medication use in young children: 1994-2009.

Chirdkiatgumchai V, Xiao H, Fredstrom BK, Adams RE, Epstein JN, Shah SS, Brinkman WB, Kahn RS, Froehlich TE.

Pediatrics. 2013 Oct;132(4):615-23. doi: 10.1542/peds.2013-1546. Epub 2013 Sep 30.

19.

Building an evidence base in complementary and integrative healthcare for child and adolescent psychiatry.

Edwards E, Mischoulon D, Rapaport M, Stussman B, Weber W.

Child Adolesc Psychiatr Clin N Am. 2013 Jul;22(3):509-29, vii. doi: 10.1016/j.chc.2013.03.007. Epub 2013 May 17. Review.

20.

What goes up must come down: the burden of bipolar depression in youth.

Van Meter AR, Henry DB, West AE.

J Affect Disord. 2013 Sep 25;150(3):1048-54. doi: 10.1016/j.jad.2013.05.039. Epub 2013 Jun 13.

Items per page

Supplemental Content

Write to the Help Desk